Endocrinology unit with 15 approved beds yet to become functional at Nishtar Hospital MULTAN: Patients suffering from diabetes and related complications are facing serious difficulties at Nishtar Hospital due ...
Pharmaceutical giant Novo Nordisk is discontinuing the country's largest selling insulin, Human Mixtard, along with other insulins. The move could shake up the diabetes market, TOI reported. Despite it ...
MUMBAI: Cipla on Wednesday said it has received the nod from Central Drugs Standard Control Organisation (CDSCO) for the exclusive distribution and marketing of Afrezza - inhalation human insulin ...
By Maggie FickLondon: Patients with type 2 diabetes taking GLP-1 treatments, which include Ozempic, have a lower chance of developing 10 types of obesity-related cancers than those taking insulin ...
Sydney: People with diabetes may soon be able to replace injections with more palatable oral forms of insulin, such as sugar-free chocolate, thanks to advances in nanotechnology. Insulin injections ...
Bengaluru: Hours after a Central Board of Secondary Education (CBSE) move barring a Type 1 diabetes student from carrying essentials like an insulin pump and carbohydrate snacks into his ...
Danish drug maker Novo Nordisk is gearing up to test the efficacy and safety of its new weekly insulin injection, IcoSema, in India. The company has got a go-ahead ...
Stem cells from the human abdomen might be transformed into cells that secrete insulin in response to rising blood sugar ranges, providing a promising method to treating diabetes, a ...